Cargando…

Pharmacotherapy for hospitalized patients with COVID-19: Waiting or doing?

Detalles Bibliográficos
Autores principales:	Amariles, Pedro, Hincapie-García, Jaime, Julio Montoya, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219394/ https://www.ncbi.nlm.nih.gov/pubmed/32405278 http://dx.doi.org/10.1016/j.sapharm.2020.05.010

Ejemplares similares

How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal
por: Amariles, Pedro, et al.
Publicado: (2021)

COVID-19 in Colombia endpoints. Are we different, like Europe?
por: Amariles, Pedro, et al.
Publicado: (2021)

Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study
por: Salazar-Ospina, Andrea, et al.
Publicado: (2020)

Relevancia clínica de las interacciones medicamentosas entre antiinflamatorios no esteroideos y antihipertensivos()
por: Villa, Juan, et al.
Publicado: (2014)

Lung cancer patients on the waiting list in the midst of the COVID-19 crisis: what do we do now?()
por: Isea de la Viña, Jesus, et al.
Publicado: (2020)

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011–2012
por: Galindo, Jaime, et al.
Publicado: (2016)

Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity
por: Lin, Kueiyu Joshua, et al.
Publicado: (2020)

Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients
por: Mendez, Carlos E., et al.
Publicado: (2014)

Emerging pharmacotherapies for COVID-19
por: Salvi, Rachana, et al.
Publicado: (2020)

Pharmacotherapy of atrial fibrillation in COVID-19 patients
por: Tomaszuk-Kazberuk, Anna, et al.
Publicado: (2021)

DGI recommendations for COVID-19 pharmacotherapy
por: Malin, Jakob J., et al.
Publicado: (2020)

The Rationale for Potential Pharmacotherapy of COVID-19
por: Saber-Ayad, Maha, et al.
Publicado: (2020)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the post-COVID-19 era()
por: García-Rojo, E., et al.
Publicado: (2021)

Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
por: Talasaz, Azita Hajhossein, et al.
Publicado: (2020)

Clinical Characteristics, Risk Factors for Severity and Pharmacotherapy in Hospitalized COVID-19 Patients in the United Arab Emirates
por: Almarashda, Amna Mohamed Juma, et al.
Publicado: (2022)

Experimental Pharmacotherapy for COVID-19: The Latest Advances
por: Pagliano, Pasquale, et al.
Publicado: (2021)

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy
por: Wang, David, et al.
Publicado: (2023)

Worth the wait: The impact of government funding on hospital emergency waiting times
por: McQuestin, Dana, et al.
Publicado: (2020)

Do trypanosome turncoats wait before they commit?
por: Ooi, Cher-Pheng, et al.
Publicado: (2014)

Pharmacotherapy of infertility in Ghana: Why do infertile patients discontinue their fertility treatment?
por: Arhin, Stephen Mensah, et al.
Publicado: (2022)

Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy
por: Heffernan, Kevin S., et al.
Publicado: (2020)

‘Waiting for’ and ‘waiting in’ public and private hospitals: a qualitative study of patient trust in South Australia
por: Ward, Paul R., et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on the surgical waiting time in urological prosthetic surgery in a tertiary hospital
por: García Formoso, N., et al.
Publicado: (2022)

The psychology of the wait time experience – what clinics can do to manage the waiting experience for patients: a longitudinal, qualitative study
por: Chu, Holly, et al.
Publicado: (2019)

The use of nebulized pharmacotherapies during the COVID-19 pandemic
por: Sethi, Sanjay, et al.
Publicado: (2020)

The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients
por: van Kimmenade, R. R. J., et al.
Publicado: (2021)

COVID-19 and the Rationale for Pharmacotherapy: A South African Perspective
por: Richards, Guy, et al.
Publicado: (2020)

Pharmacotherapy in COVID-19; A narrative review for emergency providers
por: Mehta, Nikita, et al.
Publicado: (2020)

Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality
por: AL-Taie, Anmar, et al.
Publicado: (2022)

Public's willingness to wait for COVID-19 vaccine
Publicado: (2021)

Oncofertility and COVID-19—cancer does not wait
por: Sirohi, Bhawna, et al.
Publicado: (2020)

Offline: The UK COVID-19 Inquiry—be patient, but don’t wait
por: Horton, Richard
Publicado: (2023)

Patients waiting lists and the COVID-19 pandemic: A moral dilemma
por: Miziara, Ivan Dieb, et al.
Publicado: (2021)

COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
por: Faour, Wissam H., et al.
Publicado: (2021)

Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
por: Sanak, Marek
Publicado: (2020)

Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System
por: Barkoff, Courtney M., et al.
Publicado: (2020)

Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection
por: Vitiello, Antonio, et al.
Publicado: (2022)

Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS
por: Amini, Shahideh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t20485jlaafoujsb1j47ntf4pb